Hydroa vacciniforme‐like lymphoproliferative disorder with eye involvement

Feng, Xi‐Qiao; Li, Fan; Zhang, Yi; Wang, Lin

doi:10.1111/pde.14808

Cited by 3 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Multiple reports have recently been published discussing the characteristics and prognosis of the disease. Feng et al describe the rare occurrence of ocular involvement, highlighting the importance of work-up for ophthalmic symptoms in these patients [3]. A study of 24 patients including 20 pediatric patients with hydroa vacciniforme-LPD in China found that the mortality rate of hydroa vacciniforme-LPD in the pediatric group was 31.6% (6/19, with one patient lost to follow-up) and the mean survival time for patients with childhood-onset disease was longer than that of adult-onset patients (36.4 vs. 20.8 months) [4].…”

Section: Idiopathic Photodermatosesmentioning

confidence: 99%

Photodermatoses: what's new

Scollan

Lauren

2022

Current Opinion in Pediatrics

View full text Add to dashboard Cite

Purpose of reviewThe purpose of this review is to summarize and highlight the recent literature in photodermatoses. In the past year, there have been many developments in this heterogeneous group of conditions. Recent findingsThis review is divided by photodermatoses type, which include idiopathic photodermatoses, photodermatoses secondary to exogenous agents, photodermatoses secondary to endogenous agents (the porphyrias), and genodermatoses. The idiopathic photodermatoses section focuses on case series and reports highlighting new disease presentations or further disease characterization and new treatment strategies for these disorders. The second section discusses a unique case and has a brief update on photoallergens. Clinical, diagnostic, and treatment updates for porphyrias are discussed in Section 3. For genodermatoses, we discuss complications and neoplastic risk of xeroderma pigmentosum and a few highlights from other rare disorders. Finally, we conclude with a brief overview of photoprotection updates, from assessing sun-damaged skin to the most effective photoprotective agents.

show abstract

Section: Idiopathic Photodermatosesmentioning

confidence: 99%

Photodermatoses: what's new

Scollan

Lauren

2022

Current Opinion in Pediatrics

View full text Add to dashboard Cite

show abstract

Cutaneous Photosensitivity Diseases

Ibbotson

2024

Rook's Textbook of Dermatology

View full text Add to dashboard Cite

The photodermatoses are a diverse group of conditions in which abnormal responses to light exposure are the hallmark. Photodiagnostic investigations through a specialist unit may be essential to ensure accurate diagnosis and management, and this chapter explores the nature of the photodermatoses and the photodiagnostic techniques that can be applied. Management approaches include early diagnosis, prevention and disease suppression, and awareness of the significant adverse impact on well‐being and psychological health that can occur with photosensitivity. Photoprotection is a mainstay approach for the photodermatoses but is often not sufficient alone for disease control. Desensitisation through natural hardening or light‐based therapies may be feasible, although systemic immunosuppressants and immunomodulators may be required. Awareness of the possibility of vitamin D deficiency is also necessary. This chapter will cover these approaches in detail.

show abstract